Notably, targeted knockdown of genes in the ERBB2 amplicon, including GRB7, leads to an additive effect on the decreased cell-cycle progression and cancer proliferation [57], emphasizing the importance of GRB7 coamplified with ERBB2 in their contribution to cancer proliferation. The gene discussed is GRB7; the disease is cancer.